Gait Parameters and Peripheral Neuropathy in Patients With Diabetes: A Meta-Analysis

Zhenchao Wang, Si Peng, Honghong Zhang, Hong Sun, Ji HuFrontiers in Endocrinology 2022 · DOI

Abstract

Among diabetic patients, those complicated with Diabetic Peripheral Neuropathy (DPN) possess lower gait velocity, shorter stride length, longer stride time, longer stance time, and higher maximum knee extension moment.

Introduction: The Impact of DPN on Mobility

Diabetes affects approximately 10% of the global adult population, with nearly half eventually developing Diabetic Peripheral Neuropathy (DPN). While often characterized by sensory symptoms like numbness, DPN's impact on motor control is a critical driver of morbidity. Gait abnormalities in these patients are primary precursors to "diabetic foot" ulcers and frequent falls. This meta-analysis synthesizes research to provide a definitive quantitative profile of the "DPN gait," identifying kinematic and kinetic markers to improve early diagnosis and intervention.

Methods and Data Selection

The authors conducted a systematic meta-analysis following PRISMA guidelines, aggregating data from 21 studies selected from an initial pool of 1,205 records found in PubMed, Embase, and Web of Science.

Flow diagram of the systematic study selection process.

The final dataset included 966 participants: 499 patients with DPN and 467 diabetic controls (DC) without neuropathy. Statistical analysis was performed using RevMan 5.3, employing both fixed-effect and random-effects models based on data heterogeneity ($I^2$). Quality was assessed using the AHRQ and MINORS scales.

Key Results and Insights: The "Conservative" Gait

The meta-analysis revealed significant differences across several spatiotemporal parameters, suggesting a "conservative" or "cautious" walking strategy in DPN patients. By walking slower and keeping their feet on the ground longer (increased stance time), patients likely compensate for a lack of sensory feedback.

Spatiotemporal Findings

  • Velocity: Significantly lower in the DPN group (SMD: -0.28, $p < 0.0001$).
  • Stride Length: Shorter in DPN patients (SMD: -0.19, $p = 0.04$).
  • Timing: Both stride and stance times were significantly longer in the DPN group (Stride Time WMD: 0.04s; Stance Time WMD: 0.03s).
Forest plot comparing gait velocity between DPN and DC groups across the 21 included studies.

Biomechanical Compensation

A notable finding was the higher maximum knee extension moment in DPN patients (WMD: 0.0675 N·m/kg, $p = 0.04$). This suggests that as the tibia moves forward, DPN patients must engage their quadriceps more aggressively to maintain joint stability. Interestingly, the Range of Motion (RoM) in the knee joint did not differ significantly, indicating that larger muscle groups can maintain range even if the mechanical load changes.

Limitations and Future Directions

A primary limitation is the lack of accounting for diabetic retinopathy in most studies; since vision is vital for balance, its role in gait changes remains partially obscured. Additionally, while spatiotemporal data was robust, kinetic data (like knee moments) was limited to a few studies. Future research should focus on how these specific parameters correlate with actual fall frequency to develop predictive models for clinical intervention.

Summary updated

Abstract

Among diabetic patients, those complicated with DPN possess lower gait velocity, shorter stride length, longer stride time, longer stance time, and higher maximum knee extension moment.
BibTeX
@inproceedings{wang2022gait,
  author = {Zhenchao Wang and Si Peng and Honghong Zhang and Hong Sun and Ji Hu},
  title = {{Gait Parameters and Peripheral Neuropathy in Patients With Diabetes: A Meta-Analysis}},
  booktitle = {Frontiers in Endocrinology},
  year = {2022},
  doi = {10.3389/fendo.2022.891356},
}
Figure